Scinovex
articleTop 1% cited

Clinical development success rates for investigational drugs

Nature Biotechnology · 2014 · Vol. 32(1) · pp. 40–51
Michael HayDavid W. ThomasJohn L. CraigheadCelia EconomidesJesse Rosenthal
Pharmaceutical Economics and PolicyBiotechnology and Related FieldsHealth Systems, Economic Evaluations, Quality of LifeInvestigational DrugsDrug developmentDrug approvalMedicineIntensive care medicinePharmacologyComputational biologyClinical trialInternal medicineBiology

MeSH terms

HumansUnited StatesUnited States Food and Drug AdministrationDrugs, InvestigationalDrug ApprovalBiomedical Research
Citations
2,462
FWCI
756.41
field-weighted impact
References
17
Percentile
100%
vs. same field & year
Citations per year
References
Can the pharmaceutical industry reduce attrition rates?
Nature Reviews Drug Discovery · 2004 · 4,081 citations
Risks in new drug development: Approval success rates for investigational drugs
Clinical Pharmacology & Therapeutics · 2001 · 455 citations
Related articles
Risks in new drug development: Approval success rates for investigational drugs
Clinical Pharmacology & Therapeutics · 2001 · 455 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.